Agilent TechnologiesA
Market Cap: $39.2B
About: Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.
Employees: 17,400
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
20% more call options, than puts
Call options by funds: $173M | Put options by funds: $144M
8.07% more ownership
Funds ownership: 79.46% [Q1] → 87.54% (+8.07%) [Q2]
10% more repeat investments, than reductions
Existing positions increased: 376 | Existing positions reduced: 343
0% less funds holding
Funds holding: 992 [Q1] → 990 (-2) [Q2]
2% less first-time investments, than exits
New positions opened: 97 | Existing positions closed: 99
13% less capital invested
Capital invested by funds: $37.9B [Q1] → $33.1B (-$4.79B) [Q2]
19% less funds holding in top 10
Funds holding in top 10: 16 [Q1] → 13 (-3) [Q2]
Research analyst outlook
10 Wall Street Analysts provided 1 year price targets over the past 3 months
10 analyst ratings
Wells Fargo Brandon Couillard 45% 1-year accuracy 5 / 11 met price target | 15%upside $157 | Overweight Initiated | 27 Aug 2024 |
Barclays Luke Sergott 62% 1-year accuracy 29 / 47 met price target | 1%downside $135 | Underweight Maintained | 23 Aug 2024 |
UBS Elizabeth Garcia 75% 1-year accuracy 3 / 4 met price target | 10%upside $150 | Neutral Maintained | 22 Aug 2024 |
Citigroup Patrick Donnelly 70% 1-year accuracy 19 / 27 met price target | 21%upside $165 | Buy Maintained | 22 Aug 2024 |
TD Cowen Dan Brennan 62% 1-year accuracy 16 / 26 met price target | 17%upside $160 | Buy Maintained | 22 Aug 2024 |
Financial journalist opinion
Based on 18 articles about A published over the past 30 days